VIE/MBBG (VIE/MBBG)

Vienna Stock Exchange: VIE/MBBG · EUR

€199

-4.10 (-2.0%)· Recorded snapshot

Market cap	1B
Revenue (ttm)	1.2B
Net income (ttm)	60M
EPS (ttm)	€11.3
P/E (trailing)	17.6x
P/E (forward)	19.9x
Dividend	€1.21 (0.61%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): 60M
EPS (ttm): €11.3
P/E (trailing): 17.6x
P/E (forward): 19.9x
Market cap: 1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E19.9

P25 n/aP50 n/aP75 n/a

Trailing P/E17.6

P25 n/aP50 n/aP75 n/a

ROE15.4

P25 n/aP50 n/aP75 n/a

ROIC34.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/MBBG indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

EUR

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-12
Employees	4,583
Employees change	200
Employees growth	4.99%
Enterprise value	EUR 751M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1995
Industry	Conglomerates
Is primary listing	No
ISIN number	DE000A0ETBQ4
Last earnings date	2026-08-13
Last refreshed	2026-10-30
Market cap	EUR 1B
Next earnings date	2026-11-12
Price	EUR 199.40
Price currency	EUR
Sector	Industrials
SIC code	6799
Stock price date	2026-10-29
Symbol	vie/MBBG
Website	https://www.mbb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	36.94x
Average P/E ratio (3Y)	29.83x
Average P/E ratio (5Y)	39.95x
Earnings yield	5.69%
EV/Earnings	12.52x
EV/EBIT	3.82x
EV/EBITDA	2.98x
EV/FCF	3.46x
EV/Sales	0.62x
FCF / EV yield	28.92%
FCF yield	21.03%
Forward P/E	19.94x
Graham number	228.49622
Graham upside	14.59%
Lynch fair value	EUR 289.63
Lynch upside	45.25%
P/B ratio	1x
P/E ratio	17.57x
P/FCF ratio	4.76x
P/OCF ratio	3.67x
P/S ratio	0.85x
Price / tangible book value	1.6x
Price/EBITDA ratio	4.22x
Sector forward P/E	13.76x
Sector P/E	16.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.23%
EBITDA margin	20.17%
Effective tax rate	30.35%
FCF margin	17.92%
Gross margin	53.63%
Operating margin	16.23%
Pretax margin	16.74%
Profit margin	4.95%
Profit per employee	EUR 13,093
Profitable quarters	21
Profitable years	15
Revenue per employee	EUR 264,501
ROA	8.91%
ROA (5Y)	3.72%
ROCE	16.27%
ROE	15.41%
ROE (5Y)	5.91%
ROIC	34.31%
ROIC (5Y)	13%
Tax / revenue	5.08%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	55.72%
EPS growth (Q)	78.74%
EPS growth (QoQ)	113.08%
EPS growth 10Y	19.09%
EPS growth 3Y	92.08%
EPS growth quarters	2
EPS growth years	2
FCF growth	61.5%
FCF growth 3Y	187.64%
FCF growth 5Y	95.01%
Gross profit growth	22.29%
Gross profit growth (Q)	23.1%
Gross profit growth 3Y	21.22%
Gross profit growth 5Y	13.68%
Net income growth	53.28%
Net income growth (Q)	74.77%
Net income growth (QoQ)	110.21%
Net income growth 3Y	85.25%
Net income growth quarters	2
Net income growth years	2
OCF growth	44.39%
OCF growth (Q)	18.81%
OCF growth 10Y	24.72%
OCF growth 3Y	80.74%
OCF growth 5Y	45.89%
Operating income growth	75.8%
Operating income growth (Q)	81.03%
Operating income growth 3Y	84.21%
Operating income growth 5Y	36.11%
Revenue growth	4.27%
Revenue growth (Q)	7.72%
Revenue growth (QoQ)	25.52%
Revenue growth 10Y	15.42%
Revenue growth 3Y	7.74%
Revenue growth 5Y	11.09%
Revenue growth quarters	1
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -64.2M
Depreciation and amortization	EUR 47.7M
EBIT	EUR 196.8M
EBITDA	EUR 244.5M
EPS	EUR 11.35
Financing cash flow	EUR 102.5M
Free cash flow	EUR 217.2M
Gross profit	EUR 650.2M
Income taxes	EUR 61.6M
Investing cash flow	EUR -247.4M
Net borrowing	EUR -16.2M
Net cash flow	EUR 136.8M
Net income	EUR 60M
Operating income	EUR 196.8M
Revenue	EUR 1.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.15
Book value per share	EUR 136.78
Debt / EBITDA	0.24
Debt / equity	0.06
Debt / FCF	0.28
Goodwill	EUR 48.9M
Interest coverage	60.22
Long-term assets	EUR 573.7M
Long-term liabilities	EUR 171.9M
Net cash (debt)	EUR 605.6M
Net cash / market cap	58.63%
Net cash growth	76.97%
Net debt / EBITDA	-2.48
Net debt / equity	-0.58
Net debt / FCF	-2.79
Piotroski F-Score	7
Property, plant and equipment	EUR 273.4M
Shareholders' equity	EUR 1B
Tangible book value	EUR 643.7M
Tangible book value per share	EUR 123.39
Total assets	EUR 1.5B
Total cash	EUR 666.7M
Total debt	EUR 61.1M
Total liabilities	EUR 496.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.88
Current assets	EUR 960.1M
Current liabilities	EUR 324.5M
Current ratio	2.96
Inventory turnover	9.39
Net working capital	EUR -5.1M
Quick ratio	2.73
Working capital	EUR 635.6M
Working capital turnover	2.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.55%
Dividend growth	-63.66%
Dividend growth years	1
Dividend payment date	2026-06-08
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	EUR 1.21
Dividend yield	0.61%
Ex-dividend date	2026-06-04
Last dividend	EUR 1.21
Payout ratio	10.49%
Shareholder yield	2.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 182.99
1D price change	-2.01%
1M price change	15.89%
1M total return	15.89%
1W price change	2.26%
1W total return	2.26%
1Y price change	2.57%
1Y return CAGR	3.29%
1Y total return	3.29%
20-day SMA	EUR 182.76
200-day SMA	EUR 188.56
3M price change	7.79%
3M total return	7.79%
50-day SMA	EUR 180.52
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 224.00
52-week high date	2026-02-18
52-week low	EUR 162.40
52-week low date	2026-07-13
6M price change	4.15%
6M total return	4.87%
All-time high	EUR 224.00
All-time high date	2026-02-10
All-time low	EUR 130.60
All-time low date	2025-03-20
Average true range (ATR)	EUR 4.67
Average volume	0
Change from 52-week high	-10.98%
Change from 52-week low	22.78%
Change from all-time high	-9.15%
Change from all-time low	55.82%
Change from open	-1.77%
Day's gap	-0.25%
High price	EUR 203.50
Low price	EUR 199.40
Monthly RSI	57.65
Open price	EUR 203.00
Position in 52-week range	0%
Previous close	EUR 203.50
Price vs 150-day SMA	11.21%
Price vs 20-day SMA	11.35%
Price vs 200-day SMA	7.93%
Price vs 50-day SMA	12.73%
Relative volume	20
RSI	64.68
Sharpe ratio	0.17
Sortino ratio	0.42
Weekly RSI	59.07
YTD price change	-1.69%
YTD total return	-1%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3M
Shares change (QoQ)	-1.15%
Shares change (YoY)	-1.55%
Shares held by insiders	0.6%
Shares held by institutions	4.44%

Deeper analysis on VIE/MBBG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/MBBG report

Is a complete VIE/MBBG research report available?

No complete published report is available for vie/MBBG (VIE/MBBG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/MBBG (VIE/MBBG)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/MBBG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/MBBG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/MBBG

Frequently asked questions